Filters

Certain heart failure patients are managed through cardiac resynchronisation therapy. It enables an improved and organised contraction of the heart's chambers. The heart pumps more effectively into the body due to CRT. To insert a device in the chest for cardiac resynchronisation therapy (CRT), a minimal procedure is required. CRT devices include:

Pacemaker-supported cardiac resynchronisation treatment (CRT-P): This device is designed for patients with abnormal cardiac signals and certain phases of heart failure. It sends signals that make the bottom chambers of the heart beat together. It allows the heart to fill with blood.

Cardiac resynchronisation therapy with a defibrillator (CRT-D).: An implanted cardioverter-defibrillator (ICD) and a pacemaker are employed in this combination device. For patients with heart failure who also are at risk of sudden death, it may be recommended. It can detect and correct life-threatening cardiac rhythms. It can pace the heart or shock the heart out of a life-threatening rhythm.

Cardiac Resynchronisation Therapy with a Defibrillator (CRT-D) treats certain forms of heart failure, particularly in patients with reduced ejection fraction and abnormal electrical conduction (e.g., left bundle branch block). It combines two treatments: defibrillation, which guards against sudden cardiac death brought on by potentially fatal arrhythmias, and cardiac resynchronisation, which helps the heart's chambers beat in unison. When there is a high risk of deadly arrhythmias or when medication alone is not enough to control symptoms, CRT-D is advised.

If you experience signs of heart failure, such as exhaustion, dyspnea, edema in your legs, or fainting spells, you should consult a cardiologist. CRT-D may be taken into consideration if you have been diagnosed with heart failure with reduced ejection fraction (HFrEF), particularly if your ECG shows a large QRS complex. It’s also appropriate for patients with a history of cardiac arrest or prolonged ventricular arrhythmias. The ideal time for device therapy is determined in part by early consultation.

An ECG, echocardiography, chest X-ray, and occasionally a cardiac MRI or Holter monitor will be performed to evaluate heart function and rhythm before CRT-D installation. Medication evaluations and blood tests are performed, particularly if you are taking blood thinners. Before the surgery, you will need to fast for a few hours. Your physician will outline the surgery procedures and give you preoperative instructions.

Implantation: Implantation involves inserting three leads into the heart and placing the device beneath the skin close to the left collarbone.
Programming: The device is configured to detect and prevent harmful arrhythmias and synchronise heartbeats.
Monitoring: After closing the incision, the patient is watched to ensure proper function.

The CRT-D implantation usually takes two to four hours. The majority of patients spend one to two days in the hospital. Physical activity, particularly arm motions on the implantation side, should be minimised during the typical one to two-week recovery period.

Infection or bleeding at the implant site
Lead displacement
Pneumothorax (collapsed lung)
Inappropriate shocks
Device malfunction (rare)

CRT-D dramatically lowers the risk of sudden cardiac death, improves heart function, and lessens the symptoms of heart failure. It also reduces hospitalisations and allows patients to return to regular activities with less weariness.

Recovery includes wound care, arm movement restrictions, and careful device performance monitoring. Checking battery life and modifying device settings require follow-up visits. Regular imaging, ECG monitoring, and cardiac rehabilitation are all part of long-term care.

About 70–80% of patients carefully chosen for CRT-D implantation have better cardiac function, higher quality of life, and lower mortality rates.

Top Selling Packages for CRT - D

CRT-D Package

Manipal Hospital, Dwarka, Delhi, India

USD 21500 USD 23000

Learn More

Would you like some help? We are available.

Get Help

Explore Hospitals ( 191 )

Marengo Asia Hospitals, Gurugram

Gurgaon, India

Marengo Asia Hospitals, Gurugram, is a 250-bed multi-speciality tertiary care hospital, formerly known as W Pratiksha Hospital.
A major medical centre for Delhi NCR and North India, it is situated on Golf Course Extension Road, Sector 56, Gurugram.
The hospital's NABH and NABL accreditation ensures compliance with international standards for patient care, safety, and quality.
Provides extensive medical care in more than 21 specialities, including as women's health, neurology, orthopaedics, cardiology, and cancer.
Advanced robotic-assisted spine surgery tools and neuro-monitoring technology are available at the Marengo Asia International Institute of Neuro & Spine (MAIINS), a Centre of Excellence in Neurosciences.
Equipped with cutting-edge equipment, such as automated labs, sophisticated imaging, and contemporary operating rooms.
Features specialised ICUs, NICUs, and modular OTs built for complex and minimally invasive procedures.